None listed
Conditions
Brief summary
We are doing this study to determine the most effective medication for treating women who have a miscarriage during the first three months of their pregnancy. Our clinic offers different treatment options for managing miscarriage. The first involves a single medication (Misoprostol) and the second, two separate medications (Misoprostol and Mifepristone). At present there is no evidence to show that one works better than the other. Currently, the treatment you are given depends on the women’s choice and which one the treating doctor feels will be best for the patient. Currently, it is not clear if one treatment is better than the other . We hope that this study will if adding mifepristone to the treatment improves its effectiveness so that we can better manage miscarriage.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Patients will be included who have a positive serum beta hCG and are less than 13 weeks pregnant, as determined by the size of their gestational sac or crown rump length on ultrasound. Definitions for types of miscarriage are: 1) Early embryonic demise = Mean sac diameter (MSD) >20mm with nil internal structures 2) Anembryonic pregnancy = empty gestational sac of at least 12mm and no growth over 3 or more days 3) Early fetal demise = fetus crown rump length (CRL) at least 6mm with nil fetal heart beat on transvaginal USS 4) Incomplete miscarriage = mixed echogenicity within endometrial cavity +/- disordered gestational sac
Exclusion criteria
1) severe haemorrhage or pain 2) pyrexia 3) allergy or contraindication to misoprostol or mifepristone 4) current anticoagulation